FDA.reportPublic FDA data

Qsymia 3.75/23 24 HR Extended Release Oral Capsule

RxCUI
1302845
RxNorm name
Qsymia 3.75/23 24 HR Extended Release Oral Capsule
Display name
Qsymia 3.75/23 24 HR Extended Release Oral Capsule
Full name
Qsymia 3.75/23 24 HR Extended Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
QsymiaPHENTERMINE AND TOPIRAMATEVivus LLC40dd5602-53da-45ac-bb4b-15789aba40f92026-04-22Warnings, Adverse reactionsExact identifier
rxcui: 1302845

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
40dd5602-53da-45ac-bb4b-15789aba40f9Qsymia 3.75/23 24 HR Extended Release Oral CapsuleSY42These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 201220260422
40dd5602-53da-45ac-bb4b-15789aba40f9Qsymia 3.75/23 (phentermine (as hydrochloride) / topiramate) 24 HR Extended Release Oral CapsuleSY42These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 201220260422
40dd5602-53da-45ac-bb4b-15789aba40f9Qsymia 3.75 MG / 23 MG 24HR Extended Release Oral CapsulePSN42These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 201220260422
40dd5602-53da-45ac-bb4b-15789aba40f924 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule [Qsymia]SBD42These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 201220260422
40dd5602-53da-45ac-bb4b-15789aba40f9Qsymia 3.75/23 (phentermine / topiramate) 24 HR Extended Release Oral CapsuleSY42These highlights do not include all the information needed to use QSYMIA ® safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 201220260422